Keywords: Roche, Financial results, First-half 2012
Roche first-half sales and profits beat consensus forecasts
Article | 27 July 2012
Swiss drug major Roche (ROG: SIX) yesterday presented a solid set of first-half 2012 results, with +4% growth (at constant currency (+3% local ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
